243 related articles for article (PubMed ID: 34132575)
61. Identification of specific determinants of human APOBEC3F, APOBEC3C, and APOBEC3DE and African green monkey APOBEC3F that interact with HIV-1 Vif.
Smith JL; Pathak VK
J Virol; 2010 Dec; 84(24):12599-608. PubMed ID: 20943965
[TBL] [Abstract][Full Text] [Related]
62. HIV and SIV infection: the role of cellular restriction and immune responses in viral replication and pathogenesis.
Williams KC; Burdo TH
APMIS; 2009 May; 117(5-6):400-12. PubMed ID: 19400864
[TBL] [Abstract][Full Text] [Related]
63. Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G.
Schröfelbauer B; Senger T; Manning G; Landau NR
J Virol; 2006 Jun; 80(12):5984-91. PubMed ID: 16731937
[TBL] [Abstract][Full Text] [Related]
64. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac.
Chen Z; Gettie A; Ho DD; Marx PA
Virology; 1998 Jun; 246(1):113-24. PubMed ID: 9656999
[TBL] [Abstract][Full Text] [Related]
65. A single amino acid in human APOBEC3F alters susceptibility to HIV-1 Vif.
Albin JS; LaRue RS; Weaver JA; Brown WL; Shindo K; Harjes E; Matsuo H; Harris RS
J Biol Chem; 2010 Dec; 285(52):40785-92. PubMed ID: 20971849
[TBL] [Abstract][Full Text] [Related]
66. Structural determinants of HIV-1 Vif susceptibility and DNA binding in APOBEC3F.
Siu KK; Sultana A; Azimi FC; Lee JE
Nat Commun; 2013; 4():2593. PubMed ID: 24185281
[TBL] [Abstract][Full Text] [Related]
67. Interaction between HIV-1 and APOBEC3 sub-family of proteins.
Arriaga ME; Carr J; Li P; Wang B; Saksena NK
Curr HIV Res; 2006 Oct; 4(4):401-9. PubMed ID: 17073615
[TBL] [Abstract][Full Text] [Related]
68. Dating the age of the SIV lineages that gave rise to HIV-1 and HIV-2.
Wertheim JO; Worobey M
PLoS Comput Biol; 2009 May; 5(5):e1000377. PubMed ID: 19412344
[TBL] [Abstract][Full Text] [Related]
69. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
He Z; Zhang W; Chen G; Xu R; Yu XF
J Mol Biol; 2008 Sep; 381(4):1000-11. PubMed ID: 18619467
[TBL] [Abstract][Full Text] [Related]
70. Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.
Albin JS; Harris RS
Expert Rev Mol Med; 2010 Jan; 12():e4. PubMed ID: 20096141
[TBL] [Abstract][Full Text] [Related]
71. Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV Vif.
Land AM; Wang J; Law EK; Aberle R; Kirmaier A; Krupp A; Johnson WE; Harris RS
Oncotarget; 2015 Nov; 6(37):39969-79. PubMed ID: 26544511
[TBL] [Abstract][Full Text] [Related]
72. Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease.
Rey-Cuillé MA; Berthier JL; Bomsel-Demontoy MC; Chaduc Y; Montagnier L; Hovanessian AG; Chakrabarti LA
J Virol; 1998 May; 72(5):3872-86. PubMed ID: 9557672
[TBL] [Abstract][Full Text] [Related]
73. Virus subtype-specific features of natural simian immunodeficiency virus SIVsmm infection in sooty mangabeys.
Apetrei C; Gautam R; Sumpter B; Carter AC; Gaufin T; Staprans SI; Else J; Barnes M; Cao R; Garg S; Milush JM; Sodora DL; Pandrea I; Silvestri G
J Virol; 2007 Aug; 81(15):7913-23. PubMed ID: 17507488
[TBL] [Abstract][Full Text] [Related]
74. Determinants of efficient degradation of APOBEC3 restriction factors by HIV-1 Vif.
Baig TT; Feng Y; Chelico L
J Virol; 2014 Dec; 88(24):14380-95. PubMed ID: 25275135
[TBL] [Abstract][Full Text] [Related]
75. Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm Vif.
Pery E; Rajendran KS; Brazier AJ; Gabuzda D
J Virol; 2009 Mar; 83(5):2374-81. PubMed ID: 19109396
[TBL] [Abstract][Full Text] [Related]
76. Core-binding factor subunit beta is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation.
Ai Y; Zhu D; Wang C; Su C; Ma J; Ma J; Wang X
J Virol; 2014 Oct; 88(20):12112-22. PubMed ID: 25122780
[TBL] [Abstract][Full Text] [Related]
77. Origins of HIV and the AIDS pandemic.
Sharp PM; Hahn BH
Cold Spring Harb Perspect Med; 2011 Sep; 1(1):a006841. PubMed ID: 22229120
[TBL] [Abstract][Full Text] [Related]
78. Specific Deubiquitinating Enzymes Promote Host Restriction Factors Against HIV/SIV Viruses.
Gao W; Rui Y; Li G; Zhai C; Su J; Liu H; Zheng W; Zheng B; Zhang W; Yang Y; Hua S; Yu X
Front Immunol; 2021; 12():740713. PubMed ID: 34630422
[TBL] [Abstract][Full Text] [Related]
79. Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys.
Chen Z; Luckay A; Sodora DL; Telfer P; Reed P; Gettie A; Kanu JM; Sadek RF; Yee J; Ho DD; Zhang L; Marx PA
J Virol; 1997 May; 71(5):3953-60. PubMed ID: 9094672
[TBL] [Abstract][Full Text] [Related]
80. Long-term restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif function.
Albin JS; Haché G; Hultquist JF; Brown WL; Harris RS
J Virol; 2010 Oct; 84(19):10209-19. PubMed ID: 20686027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
